Page 31 - GTM-1-1
P. 31

Global Translational Medicine                              Inflammatory gene-environment interactions in COPD




            Table 3. Distributions of genotypes and alleles of studied inflammatory gene loci in smokers
            Gene, SNP  Minor   Genotypes and  COPD patients, n (%) (N=484) Healthy individuals, n (%)   P‑value a  P‑value b  OR (95% CI)
                     allele  alleles                         (N=517)
            FASLG,   T      CC/CT/TT   225/183/76 (46.49/37.81/15.70)  221/229/67 (42.75/44.29/12.96)  0.11  0.88  0.99 (0.82 – 1.18)
            rs763110        C/T        633/335 (65.39/34.61)  671/363 (64.89/35.11)  0.852   -    0.97 (0.81 – 1.17)
            C>T
            IL19,    A      GG/GA/AA   237/149/98 (48.97/30.79/20.25) 163/239/115 (31.53/46.23/22.24)  0.00001  0.0003  0.72 (0.60 – 0.86)
            rs2243193       G/A        623/345 (64.36/35.64)  565/469 (54.64/45.36)  0.00001  -   0.67 (0.56 – 0.80)
            A>G
            IL20,    G      AA/AG/GG   243/190/51 (50.21/39.26/10.54)  241/216/60 (46.62/41.78/11.61)   0.57  0.31  0.90 (0.74 – 1.10)
            rs2981573       A/G        676/292 (69.83/30.17)  698/336 (67.50/32.50)  0.283   -    0.88 (0.74 – 1.08)
            A>G
            IL24,    C      TT/TC/CC   155/214/115 (32.02/44.21/23.76) 156/237/124 (30.17/45.84/23.98)  0.82  0.66  0.96 (0.81 – 1.15)
            rs291107        T/C        524/444 (54.13/45.87)  549/485 (53.09/46.91)  0.674   -    0.96 (0.80 – 1.14)
            T>C
            PPBP,    T      CC/CT/TT   353/76/55 (72.93/15.70/11.36)  319/170/28 (61.70/32.88/5.42)  0.00001  0.21  0.88 (0.72 – 1.07)
            rs352010        C/T        782/186 (80.79/19.21)  808/226 (78.14/21.86)  0.160   -    0.85 (0.68 – 1.06)
            T>C
            IL4,     T      CC/CT/TT   253/192/39 (52.27/39.67/8.06)  306/188/23 (59.19/36.36/4.45)   0.038  0.014  1.33 (1.06 – 1.66)
            rs2243250       C/T        698/270 (72.11/27.89)  800/234 (77.37/22.63)  0.003   -    1.32 (1.08 – 1.62)
            C>T
            IL4,     T      CC/CT/TT   324/158/2 (66.94/32.64/0.41)  308/183/26 (59.57/35.40/5.03)  0.00001  0.0006  0.66 (0.52 – 0.84)
            rs2070874       C/T        806/162 (83.26/16.74)  799/235 (77.27/22.73)  0.00001  -   0.68 (0.55 – 0.85)
            C>T
            С5, rs17611  A  GG/GA/AA   152/231/101 (31.40/47.73/20.87) 171/238/108 (33.08/46.03/20.89)  0.86  0.74  1.03 (0.86 – 1.24)
            G>A             G/A        535/433 (55.27/44.73)  580/454 (56.09/43.91)  0.744   -    1.03 (0.87 – 1.23)
            FAS,     G      AA/AG/GG   169/214/101 (34.92/44.21/20.87) 156/250/111 (30.17/48.36/21.47)  0.32  0.29  0.91 (0.75 – 1.09)
            rs1800682       A/G        552/416 (57.02/42.98)  562/472 (54.35/45.65)  0.247   -    0.90 (0.75 – 1.07)
            A>G
            IL4RA,   G      AA/AG/GG   166/206/112 (34.30/42.56/23.14) 163/247/107 (31.53/47.78/20.70)  0.32  0.89  0.99 (0.83 – 1.18)
            rs1805010       A/G        538/430 (55.58/44.42)  573/461 (55.42/44.58)  0.798   -    0.99 (0.83 – 1.19)
            A>G
            TGFb1,   T      CC/CT/TT   229/201/54 (47.31/41.53/11.16)  222/230/65 (42.94/44.49/12.57)  0.43  0.21  0.88 (0.72 – 1.07)
            rs1800469       C/T        659/309 (68.08/31.92)  674/360 (65.18/34.82)  0.185   -    0.88 (0.73 – 1.06)
            T>C
            a P-value for Chi-square test;  P-value for Cochran-Armitage trend test. CI, confidence interval; OR, odds ratio.
                              b
              The association of IL4 (rs2243250) and COPD in smokers   patients and healthy individuals groups (P = 0.00001)
            was detected (P = 0.003, OR =1.32 for basic allele test), in   (Table 6). Significant association of T-C haplotype by
            the log-additive (P =0.014, P cor-FDR  =0.019, OR =1.33), and   rs2243250 and rs2070874 loci of IL4 gene with COPD
                          adj
            recessive (P =0.036,  P cor-FDR  =0.041, OR  =1.85) models   risk in smokers was observed (P =0.024, OR =1.44).
                     adj
                                                                                           adj
            (Tables 3 and 5). The frequency of minor T allele of IL4   The C-T haplotype by rs2243250 and rs2070874 of IL4
            (rs2070874) in patients group was decreased (16.74% in   gene was identified as protective (P  =0.001, OR =0.52;
                                                                                            adj
            COPD vs. 22.73% in control P = 0.00001, OR =0.68 for basic   Table 6).
            allele test). IL4 (rs2070874) was associated with COPD in   Association of PPBP (rs352010) with the development
            smokers in the log-additive (P =0.0006, P cor-FDR  =0.0018,   of COPD in smokers was detected in the recessive
                                     adj
            OR =0.66) and recessive (P =0.00001, P cor-FDR  =7.5 × 10 ,   (P   =0.0008,  P   =0.002, OR =2.26), and dominant
                                                         -5
                                  adj 
                                                                 adj
            OR =0.08) models (Table 5).                        (P =0.0002, P  cor-FDR =0.001, OR =0.60) models (Table 5).
                                                                           cor-FDR
                                                                 adj
              Moderate level of linkage disequilibrium between   A  significant interaction of the  PPBP  (rs352010) and
            the  rs2243250  and  rs2070874  loci  of  IL4  gene  was   smoking status was detected in the regression analysis
            observed (D’  =0.46, r = 0.15) (Figure  1). We have   (P interact  =0.017, OR =0.60, 95% CI =0.46 – 0.79 in the
                                   
                               2 
            established significant differences in the haplotype   dominant model).  PPBP  (rs352010) was predominantly
            frequencies  distribution of  IL4 gene  loci between   associated with COPD in smokers.
            Volume 1 Issue 1 (2022)                         5                       https://doi.org/10.36922/gtm.v1i1.91
   26   27   28   29   30   31   32   33   34   35   36